How much revenue does Myrexis make?

Myrexis reported $0 in revenue for fiscal year 2013.

What companies are similar to Myrexis?

Listed companies of a similar size in the same industry (acquisition vehicle corporations) include Rino International Corporation (RINO), Xiamen Lutong International Travel Agency Co. Ltd. (LTGJ), Hypertension Diagnostics, Inc. (HDII), Viscount Systems, Inc. (VSYS).

Myrexis, Inc. (MYRX) Stock

About Myrexis, Inc.

Myrexis, Inc. focuses on identifying, evaluating, and making financial investments in life sciences assets. The company was formerly known as Myriad Pharmaceuticals, Inc. and changed its name to Myrexis, Inc. in July 2010. Myrexis, Inc. is headquartered in New York, New York.

At a glance

Myrexis reported revenue of $0 for fiscal year 2013, and net income of -$11.62 million.

Figures from company filings; latest fiscal year ended June 30, 2013.

No profile data available.

Disclaimer: This analysis is for informational and educational purposes only and does not constitute financial, investment, tax, or legal advice. Data may be incomplete, delayed, or contain inaccuracies. Consult with a qualified financial advisor before making any investment decisions.